Intraoperative Radiotherapy for Breast Cancer in Elderly Women

被引:4
|
作者
Guillerm, S. Ophie [1 ,2 ]
Bourstyn, Edwige [1 ,2 ]
Itti, Ramona [1 ,2 ]
Cahen-Doidy, Laurence [1 ,2 ]
Quero, Laurent [1 ,2 ]
Labidi, Mouna [1 ,2 ]
Marchand, Eva [1 ,2 ]
Lorphelin, Henri [1 ,2 ]
Giacchetti, Sylvie [1 ,2 ]
Cuvier, Caroline [1 ,2 ]
Espie, Marc [1 ,2 ]
Teixeira, Luis [1 ,2 ]
Hennequin, Christophe [1 ,2 ]
机构
[1] St Louis Hosp, Radiat Oncol Dept, Paris, France
[2] St Louis Hosp, Breast Canc Unit, Paris, France
关键词
Breast cancer; Intraoperative radiotherapy; Local control; Cosmetic result; LUMPECTOMY PLUS TAMOXIFEN; KILOVOLTAGE X-RAYS; CONSENSUS STATEMENT; CONSERVING SURGERY; RADIATION-THERAPY; IRRADIATION; RECURRENCE; OLDER; METAANALYSIS; MORTALITY;
D O I
10.1016/j.clbc.2021.05.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Intraoperative radiotherapy (IORT) with low-energy photons was delivered to 191 women >65 years of age. Only 8 patients had postoperative external beam radiotherapy. 5-year local relapse rate was 1.7%. Postoperative complications were rare, without delay in wound healing, even in older women. Cosmetic result was good or excellent in >90% of the patients. Purpose: To evaluate outcomes and postoperative toxicities after intraoperative radiotherapy (IORT) in elderly women. Population: Women older than 65 years, with infiltrating ductal breast cancer <= 3 cm, expressing estrogen receptor (ER+) without Her2 overexpression, and with negative axillary nodes. Treatment: Treatment consisted of partial mastectomy with a sentinel lymph node biopsy (SLNB) procedure; in case of positive SLNB, IORT was cancelled. IORT consisted in a total dose of 20 Gy in 1 fraction delivered at the surface of the applicator with the Intrabeam (R) technique. Results: IORT was planned to be administered to a total of 225 patients but was cancelled for 34 patients during surgery. Thus 191 patients were analyzed; mean age was 76 years, with 57 patients (30%) >80 years. Despite inclusion criteria, 15 had lobular carcinoma and 7 were triple negative. With a median follow-up of 40 months, we observed only 1 local recurrence, located in the skin over the initial tumor. The 5-year local relapse rate was 1.7%. A wound healing delay ( >15 days) was observed in 21 patients (11%). Sixty-six patients (35%) had postoperative complications, mainly grade 2, resolving within a few days. Two patients needed surgical drainage for local abscesses. Long-term ( >1 year) cosmetic outcome was evaluated in 120 patients and was judged excellent or good in 102 (91%). Conclusion: IORT can be safely given to elderly women, with a good local control rate and without major toxicities. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:E109 / E113
页数:5
相关论文
共 50 条
  • [31] Guiding Sole Intraoperative Radiotherapy in Breast Cancer According to ASTRO Guidelines: Mitigating Adverse Outcomes in a Taiwan Single-Center
    Yang, Hsin-Yi
    Tsang, Yuk-Wah
    Tu, Chi-Wen
    Hsu, Yu-Chen
    CANCER MEDICINE, 2025, 14 (01):
  • [32] Breast cancer electron intraoperative radiotherapy: assessment of preoperative selection factors from a retrospective analysis of 758 patients and review of literature
    Takanen, S.
    Gambirasio, A.
    Gritti, G.
    Kaelli, M.
    Andreoli, S.
    Fortunato, M.
    Feltre, L.
    Filippone, F. R.
    Iannacone, E.
    Maffioletti, L.
    Muni, R.
    Piccoli, F.
    Mauri, E. M. P.
    Paludetti, A.
    Giovanelli, M.
    Burgoa, L.
    Valerii, C.
    Palamara, F.
    Ferro, M.
    Fenaroli, P.
    Tondini, C. A.
    Cazzaniga, L. F.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 165 (02) : 261 - 271
  • [33] Intraoperative radiotherapy in women with early breast cancer treated by breast-conserving therapy
    Chua, Boon H.
    Henderson, Michael A.
    Milner, Alvin D.
    ANZ JOURNAL OF SURGERY, 2011, 81 (1-2) : 65 - 69
  • [34] Intraoperative Radiotherapy for Breast Cancer: Its Perceived Simplicity
    Ash, Robert B.
    Williams, Venita L.
    Wagman, Lawrence D.
    Forouzannia, Afshin
    ONCOLOGY-NEW YORK, 2013, 27 (02): : 107 - 113
  • [35] First description of MR mammographic findings in the tumor bed after intraoperative radiotherapy (IORT) of breast cancer
    Wasser, Klaus
    Schnitzer, Andreas
    Engel, Dorothee
    Krammer, Julia
    Wenz, Frederik
    Kraus-Tiefenbacher, Uta
    Suetterlin, Marc
    Schoenberg, Stefan O.
    Weisser, Gerald
    CLINICAL IMAGING, 2012, 36 (03) : 176 - 184
  • [36] The role of radiotherapy in elderly women with early-stage breast cancer treated with breast conserving surgery
    Valli, Mariacarla
    Cima, Simona
    Fanti, Paola
    Muoio, Barbara
    Vanetti, Alessandra
    Azinwi, Che N.
    Yordanov, Kaloyan
    Martucci, Francesco
    Pesce, Gianfranco A.
    Canonica, Claudia
    Richetti, Antonella
    TUMORI JOURNAL, 2018, 104 (06): : 429 - 433
  • [37] 21-Gene Recurrence Score Assay and Outcomes of Adjuvant Radiotherapy in Elderly Women With Early-Stage Breast Cancer After Breast-Conserving Surgery
    Wu, San-Gang
    Zhang, Wen-Wen
    Wang, Jun
    Dong, Yong
    Sun, Jia-Yuan
    Chen, Yong-Xiong
    He, Zhen-Yu
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [38] The evolving role of adjuvant radiotherapy for elderly women with early-stage breast cancer
    Rutter, Charles E.
    Lester-Coll, Nataniel H.
    Mancini, Brandon R.
    Corso, Christopher D.
    Park, Henry S.
    Yeboa, Debra N.
    Gross, Cary P.
    Evans, Suzanne B.
    CANCER, 2015, 121 (14) : 2331 - 2340
  • [39] Case Report: Bilateral targeted intraoperative radiotherapy: a safe and effective alternative for synchronous bilateral breast cancer
    Bhimani, Fardeen
    Mcevoy, Maureen
    Gupta, Anjuli
    Pastoriza, Jessica
    Shihabi, Areej
    Basavatia, Amar
    Tome, Wolfgang A.
    Fox, Jana
    Mehta, Keyur
    Feldman, Sheldon
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [40] Case Report: Can Targeted Intraoperative Radiotherapy in Patients With Breast Cancer and Pacemakers be the New Standard of Care?
    Bhimani, Fardeen
    Johnson, Kelly
    Brodin, N. Patrik
    Tome, Wolfgang A.
    Fox, Jana
    Mehta, Keyur
    McEvoy, Maureen
    Feldman, Sheldon
    FRONTIERS IN ONCOLOGY, 2022, 12